Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
3 point » 3d point (Expand Search), 3 points (Expand Search), _ point (Expand Search)
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
3 point » 3d point (Expand Search), 3 points (Expand Search), _ point (Expand Search)
-
741
The average speed of the model (step length/step duration), <i>v</i>, vs. the phase of a perturbation pulse, <i>φ</i> for a pulse of constant amplitude and duration.
Published 2013“…<p>When a pulse is located in a swing phase, it cannot accelerate the model, and <i>v</i> is lower than when the entire pulse is inside double stance. …”
-
742
-
743
Temporal profiles of the key BO-NN features.
Published 2020“…Right plot show the gradual decrease in the TM tuning for the features highlighted in <b>c</b> as well as the gradual increase in the temporal response profile (i.e. optimal shifts for the prediction of the key BO-NN features using Praat features shown in <b>a</b>). …”
-
744
-
745
-
746
-
747
Overview of study procedures.
Published 2025“…VIDEO and CONTROL were associated with a similar rise in intent to decrease OTC NSAID use (1.92 (SD: 4.41) vs. 1.36 (SD: 3.46), p = 0.150) and a similar decrease in NSAIDs exposure (−32.8% in VIDEO and −36.5% in CONTROL, p = 0.520) 4 weeks post-intervention. …”
-
748
-
749
-
750
-
751
-
752
-
753
-
754
-
755
-
756
-
757
-
758
-
759
-
760
MeV <i>M</i> mRNA quantification in cells treated with an inhibitor of RNA polymerase III.
Published 2023Subjects: